Minnesota · Nonprofit
National Institute for Pharmaceutical Technology and Education Inc
National Institute for Pharmaceutical Technology and Education Inc (Minnesota) receives grants from 2 organizations whose IRS filings report $431,609 to it, the largest being UNIVERSITY OF DELAWARE ($406,609). 1 of them have funded it in more than one year.
- Revenue FY2025
- $3.5M
- Funders on record
- 2
- Grants received
- $432k
- Net assets
- $1.1M
What National Institute for Pharmaceutical Technology and Education Inc does
Mission
The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chain resilience--ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
As stated on its FY2025 Form 990.
Program
During FY25, NIPTE completed or continued work on three major research projects. These projects support NIPTE's mission to make medicines more affordable and of higher quality. In addition, NIPTE supported the education component by developing and delivering advanced pharmaceutical topics to the workforce.
$3,136,667 spentof which $3,089,367 as grants$2,383,246 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $3,136,667.
The organization over time
Each line starts at 100 in 2018, so what you read is the shape rather than the size: 150 means half as much again as 2018, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $1.4M to $3.1M (+129%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2018 90% · 2021 45% · 2022 21% · 2023 48% · 2024 52% · 2025 21%. Grants only. Government contracts and fees sit inside program revenue.
31% of National Institute for Pharmaceutical Technology and Education Inc’s revenue is contributions — more earned-revenue than three-quarters of its peers (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 6 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Vadim J Gurvich
Executive Director
Board chair
James K Drennen
Chair
As listed on its FY2025 Form 990.
Who funds it, year by year
2021 → 2023: the base narrowed from 2 funders to 1 funder, grant income rose $60k → $346k.
From the IRS filings of National Institute for Pharmaceutical Technology and Education Inc’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
National Institute for Pharmaceutical Technology and Education Inc leans on a few funders — its largest provides 94% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund National Institute for Pharmaceutical Technology and Education Inc.
Largest funder’s share by year: 2021 58% · 2022 100% · 2023 100% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
National Institute for Pharmaceutical Technology and Education Inc draws 100% of its grant income from funders outside Minnesota, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
National Institute for Pharmaceutical Technology and Education Inc's funding has concentrated — grant income rose while the number of funders held roughly flat.
this organization peer median middle 50% of peers· 1,504 philanthropy nonprofits $1M–$10M, FY2025
Government funding National Institute for Pharmaceutical Technology and Education Inc receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $18.3M on record.
- Department of Health and Human Services$18.2M
- National Science Foundation$85k
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like National Institute for Pharmaceutical Technology and Education Inc
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Minnesota
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
91% of spending goes to programs.
Governance
Footprint & structure
Part of a family of 22 related entities
- Duquesne University · exempt
- Purdue University · exempt
- Rutgers University · exempt
- Texas A&M University · exempt
- University of Texas at Austin · exempt
Screen this organization
A dated, signed PDF of the compliance screen for National Institute for Pharmaceutical Technology and Education Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds National Institute for Pharmaceutical Technology and Education Inc?
- National Institute for Pharmaceutical Technology and Education Inc (Minnesota) receives grants from 2 organizations whose IRS filings report $431,609 to it, the largest being UNIVERSITY OF DELAWARE ($406,609). 1 of them have funded it in more than one year.
- How many funders does National Institute for Pharmaceutical Technology and Education Inc have?
- IRS filings report 2 organizations giving $431,609 in grants to National Institute for Pharmaceutical Technology and Education Inc, 1 of which have funded it in more than one year.
- Who is the largest funder of National Institute for Pharmaceutical Technology and Education Inc?
- UNIVERSITY OF DELAWARE is the largest funder on record, with $406,609 in grants. The full list of funders is on this page.
- How can an organization like National Institute for Pharmaceutical Technology and Education Inc find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Minnesota. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2018–2025), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing